Skip to main content
. 2024 Nov 29;10(48):eadr5145. doi: 10.1126/sciadv.adr5145

Fig. 1. Schematic illustration of TPAD-COF NP-mediated PEDT for tumor treatment and lung metastasis inhibition.

Fig. 1.

(A and B) Schematic diagram of (A) the fabrication of TPAD-COF NPs and (B) their application in pyroelectric catalysis-activated immunotherapy.